Lidocaine Hydrochloride Topical Solution USP 4%
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
18,003 recalls, newest first
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Subpotent drug
Subpotent drug
Failed Dissolution Specifications
Failed viscosity specification - product was below specificcation
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
cGMP Deviations
Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse